Literature DB >> 27589549

Necrotizing enterocolitis in premature infants and newborns.

M J Mϋller1, T Paul1, S Seeliger1,2.   

Abstract

Necrotizing enterocolitis (NEC) is the most common acquired disease of the gastrointestinal tract (GIT) in premature infants and newborns. It is defined as an ulcerative inflammation of the intestinal wall. The clinical signs of incipient NEC are often very discrete, and range from localized intestinal symptoms to generalized signs of sepsis. NEC is classified depending on its severity into disease states according to the modified Bell's Classification. Treatment of NEC ranges, depending on its severity, from a conservative therapeutic approach to surgery with resection of the affected parts of the intestine. Mortality is considerably high in extremely small preterm infants reaching up to 42% of the affected children. Measures such as breastfeeding or alternatively nutrition with pasteurized human donor milk from a milk bank, administration of probiotics, avoidance of histamine type II receptor antagonists, and restrictive antibiotic treatment should be considered early on for prevention of NEC.

Entities:  

Keywords:  Necrotizing enterocolitis; breast milk; lactoferrin; peritoneal drainage; probiotics

Mesh:

Substances:

Year:  2016        PMID: 27589549     DOI: 10.3233/NPM-16915130

Source DB:  PubMed          Journal:  J Neonatal Perinatal Med        ISSN: 1878-4429


  14 in total

1.  [A review on the characteristics of microbiome and their association with diseases in preterm infants].

Authors:  Qiong Jia; Xiao-Mei Tong
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-11

2.  In silico analysis of the human milk oligosaccharide glycome reveals key enzymes of their biosynthesis.

Authors:  Andrew G McDonald; Julien Mariethoz; Gavin P Davey; Frédérique Lisacek
Journal:  Sci Rep       Date:  2022-06-27       Impact factor: 4.996

3.  SIRT1 relieves Necrotizing Enterocolitis through inactivation of Hypoxia-inducible factor (HIF)-1a.

Authors:  Ming Bai; Chaoxiang Lu; Lu An; Qi Gao; Weike Xie; Feng Miao; Xiaofeng Chen; Yongkang Pan; Qi Wang
Journal:  Cell Cycle       Date:  2020-07-13       Impact factor: 4.534

Review 4.  Para-probiotics for Preterm Neonates-The Next Frontier.

Authors:  Girish Deshpande; Gayatri Athalye-Jape; Sanjay Patole
Journal:  Nutrients       Date:  2018-07-05       Impact factor: 5.717

5.  Peptidomics Analysis Discloses That Novel Bioactive Peptides Participate in Necrotizing Enterocolitis in a Rat Model.

Authors:  Yiwen Liu; Changlin Wang; Renqiang Yu; Jianfeng Fan; Weilai Jin; Yuting Zhu; Yingzuo Shi; Yulei Jing; Xiaolei Wang; Zhengying Li; Jian Zhou; Le Zhang
Journal:  Biomed Res Int       Date:  2020-12-31       Impact factor: 3.411

6.  Early Protein Markers of Necrotizing Enterocolitis in Plasma of Preterm Pigs Exposed to Antibiotics.

Authors:  Yan-Nan Jiang; Tik Muk; Allan Stensballe; Duc Ninh Nguyen; Per Torp Sangild; Ping-Ping Jiang
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

7.  Effects of nutrition therapy on growth, inflammation and metabolism in immature infants: a study protocol of a double-blind randomized controlled trial (ImNuT).

Authors:  Kristina Wendel; Helle Cecilie Viekilde Pfeiffer; Drude Merete Fugelseth; Eirik Nestaas; Magnus Domellöf; Bjorn Steen Skålhegg; Katja Benedikte Presto Elgstøen; Helge Rootwelt; Rolf Dagfinn Pettersen; Are Hugo Pripp; Tom Stiris; Sissel J Moltu
Journal:  BMC Pediatr       Date:  2021-01-07       Impact factor: 2.125

8.  [Radiological evaluation of acute abdomen in children].

Authors:  P C Krüger; H J Mentzel
Journal:  Radiologe       Date:  2019-02       Impact factor: 0.635

Review 9.  The role of imaging in the management of necrotising enterocolitis: a multispecialist survey and a review of the literature.

Authors:  Margareta Ahle; Hans G Ringertz; Erika Rubesova
Journal:  Eur Radiol       Date:  2018-03-26       Impact factor: 5.315

10.  An exclusive human milk diet for very low birth weight newborns-A cost-effectiveness and EVPI study for Germany.

Authors:  Stefan Michael Scholz; Wolfgang Greiner
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.